Suppr超能文献

NLRP12-PANoptosome 响应血红素和 PAMPs 激活 PANoptosis 和病理学。

NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMPs.

机构信息

Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.

Animal Resources Center and the Veterinary Pathology Core, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.

出版信息

Cell. 2023 Jun 22;186(13):2783-2801.e20. doi: 10.1016/j.cell.2023.05.005. Epub 2023 Jun 1.

Abstract

Cytosolic innate immune sensors are critical for host defense and form complexes, such as inflammasomes and PANoptosomes, that induce inflammatory cell death. The sensor NLRP12 is associated with infectious and inflammatory diseases, but its activating triggers and roles in cell death and inflammation remain unclear. Here, we discovered that NLRP12 drives inflammasome and PANoptosome activation, cell death, and inflammation in response to heme plus PAMPs or TNF. TLR2/4-mediated signaling through IRF1 induced Nlrp12 expression, which led to inflammasome formation to induce maturation of IL-1β and IL-18. The inflammasome also served as an integral component of a larger NLRP12-PANoptosome that drove inflammatory cell death through caspase-8/RIPK3. Deletion of Nlrp12 protected mice from acute kidney injury and lethality in a hemolytic model. Overall, we identified NLRP12 as an essential cytosolic sensor for heme plus PAMPs-mediated PANoptosis, inflammation, and pathology, suggesting that NLRP12 and molecules in this pathway are potential drug targets for hemolytic and inflammatory diseases.

摘要

细胞质先天免疫传感器对于宿主防御至关重要,并形成复合物,如炎症小体和 PANoptosomes,诱导炎症细胞死亡。传感器 NLRP12 与感染和炎症性疾病有关,但它的激活触发因素及其在细胞死亡和炎症中的作用仍不清楚。在这里,我们发现 NLRP12 可响应血红素加 PAMPs 或 TNF 驱动炎症小体和 PANoptosomes 的激活、细胞死亡和炎症。TLR2/4 介导的通过 IRF1 的信号转导诱导 Nlrp12 表达,从而导致炎症小体形成,诱导 IL-1β 和 IL-18 的成熟。炎症小体也是更大的 NLRP12-PANoptosomes 的一个组成部分,通过 caspase-8/RIPK3 驱动炎症性细胞死亡。Nlrp12 的缺失可保护小鼠免受溶血性模型中的急性肾损伤和致死性。总体而言,我们确定 NLRP12 是血红素加 PAMPs 介导的 PANoptosis、炎症和病理学的必需细胞质传感器,表明 NLRP12 和该途径中的分子是溶血性和炎症性疾病的潜在药物靶点。

相似文献

1
NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMPs.
Cell. 2023 Jun 22;186(13):2783-2801.e20. doi: 10.1016/j.cell.2023.05.005. Epub 2023 Jun 1.
3
NLRC5 senses NAD depletion, forming a PANoptosome and driving PANoptosis and inflammation.
Cell. 2024 Jul 25;187(15):4061-4077.e17. doi: 10.1016/j.cell.2024.05.034. Epub 2024 Jun 14.
4
NLRP12 drives PANoptosis in response to heme.
Trends Immunol. 2023 Aug;44(8):574-576. doi: 10.1016/j.it.2023.06.008. Epub 2023 Jul 7.
5
Therapeutic potential of PANoptosis: innate sensors, inflammasomes, and RIPKs in PANoptosomes.
Trends Mol Med. 2024 Jan;30(1):74-88. doi: 10.1016/j.molmed.2023.10.001. Epub 2023 Nov 15.
6
PANoptosis: Emerging mechanisms and disease implications.
Life Sci. 2023 Nov 15;333:122158. doi: 10.1016/j.lfs.2023.122158. Epub 2023 Oct 6.
7
Single cell analysis of PANoptosome cell death complexes through an expansion microscopy method.
Cell Mol Life Sci. 2022 Sep 28;79(10):531. doi: 10.1007/s00018-022-04564-z.
8
ZBP1 promotes fungi-induced inflammasome activation and pyroptosis, apoptosis, and necroptosis (PANoptosis).
J Biol Chem. 2020 Dec 25;295(52):18276-18283. doi: 10.1074/jbc.RA120.015924. Epub 2020 Oct 27.
10
The NLR family of innate immune and cell death sensors.
Immunity. 2024 Apr 9;57(4):674-699. doi: 10.1016/j.immuni.2024.03.012.

引用本文的文献

2
Targeting PANoptosis: a promising therapeutic strategy for ALI/ARDS.
Apoptosis. 2025 Sep 4. doi: 10.1007/s10495-025-02168-z.
3
PANoptosis in cancer: molecular mechanisms and therapeutic potential.
Cancer Gene Ther. 2025 Aug 21. doi: 10.1038/s41417-025-00940-6.
4
RPA1 protects DNA damage-induced PANoptosis in limb development.
Sci Adv. 2025 Aug 22;11(34):eadw2756. doi: 10.1126/sciadv.adw2756. Epub 2025 Aug 20.
5
A potential strategy to rebuild the tumor immune microenvironment: PANoptosis.
Front Immunol. 2025 Aug 4;16:1626411. doi: 10.3389/fimmu.2025.1626411. eCollection 2025.
6
Diverse functions of NLRP3 inflammasome in PANoptosis and diseases.
Cell Death Discov. 2025 Aug 19;11(1):389. doi: 10.1038/s41420-025-02689-1.
9
PANoptosis in cancer: bridging molecular mechanisms to therapeutic innovations.
Cell Mol Immunol. 2025 Jul 28. doi: 10.1038/s41423-025-01329-z.
10
Three decades of caspases and RIPKs in life and death.
Hum Mol Genet. 2025 Jul 25. doi: 10.1093/hmg/ddaf106.

本文引用的文献

1
Oxidized thioredoxin-1 restrains the NLRP1 inflammasome.
Sci Immunol. 2022 Nov 11;7(77):eabm7200. doi: 10.1126/sciimmunol.abm7200. Epub 2022 Nov 4.
2
P38 kinases mediate NLRP1 inflammasome activation after ribotoxic stress response and virus infection.
J Exp Med. 2023 Jan 2;220(1). doi: 10.1084/jem.20220837. Epub 2022 Oct 31.
4
Hemolytic Anemia Complicating COVID-19 Infection.
J Hematol. 2021 Oct;10(5):221-227. doi: 10.14740/jh906. Epub 2021 Oct 5.
5
ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis.
Cell Rep. 2021 Oct 19;37(3):109858. doi: 10.1016/j.celrep.2021.109858.
7
AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence.
Nature. 2021 Sep;597(7876):415-419. doi: 10.1038/s41586-021-03875-8. Epub 2021 Sep 1.
9
CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death.
iScience. 2021 Jul 23;24(7):102711. doi: 10.1016/j.isci.2021.102711. Epub 2021 Jun 10.
10
DPP9 sequesters the C terminus of NLRP1 to repress inflammasome activation.
Nature. 2021 Apr;592(7856):778-783. doi: 10.1038/s41586-021-03350-4. Epub 2021 Mar 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验